All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.

The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy
Steering CommitteeAbout UsNewsletterContact
Visit:
ALL HubAML HubGVhD HubMDS HubMPN HubMultiple Myeloma
Steering CommitteeAbout UsNewsletterContact
SubtypesTherapeuticsCongressesTrialsExpert Opinions
COSTEM 2021

Prof. Stephen J. Schuster | ICML 2017 | Interim results of the JULIET trial of CTL019 in R/R DLBCL

By Anne Villeneuve, Stephanie Hill
Featured
Stephen J. Schuster
Jun 19, 2017
Share:

Interim results of the JULIET trial of CTL019 in R/R DLBCL

Share:
More about...
Aggressive B-cell lymphomasDiffuse large B-cell lymphomaICML 2017JULIETTisagenlecleucel

Related articles

Newsletter

Subscribe to get the best content related to lymphoma & CLL delivered to your inbox